Skip to main content
 

Kris Vijay, MD, MS, FACC, FACP, FNLA, FHFSA

Kris Vijay, MD, MS, FACC, FACP, FNLA, FHFSA

Kris Vijay (Krishnaswami Vijayaraghavan, MD, MS, FACC, FACP, FNLA, FHFSA) is a noninvasive Heart Failure cardiologist and President of Innovative Cardiometabolic Center, a medical and healthcare consultant, advising many pharmaceutical, biotech and device industries He was recently the Medical Director of the Institute of Congestive Heart Failure at Abrazo Arizona Heart Hospital and Abrazo Health Network. He is a trained endocrinologist, Lipidologists, an ardent researcher and a Heart Failure specialist. Dr. Vijay graduated from Kasturba Medical College, University of Mysore, completed postgraduate training in medicine and Nephrology at KEM Hospital in Bombay, India, Oxford Region, UK, and Rochester, NY, Endocrinology and Diabetes fellowship from U of Southampton, UK, and a fellowship in cardiology at Banner University Medical Center Phoenix. He holds a master’s degree in clinical research design and statistical analysis from the University of Michigan’s School of Public Health. Dr. Vijay serves as a Clinical Professor of Medicine at U of Arizona, Phoenix

More News

  • Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology

  • AccurKardia receives patent for AI-ECG cardiac amyloidosis detection

  • Rewriting Early Detection: How AI Is Redefining Cardiovascular Diagnostics